Safety and Efficacy in Patients Receiving Maintenance Rituximab for Follicular Lymphoma: Early Results From Phase IIIb MAXIMA Trial

被引：0
|
作者：
Witzens-Harig, Mathias [10 ]
van Hazel, Guy [9 ]
Chamone, Dalton F. A. [8 ]
Ruffert, Klaus [2 ]
Rowe, Jacob M. [1 ]
Lazzarino, Mario [4 ]
Foa, Robin [3 ]
Poddubnaya, Irina [7 ]
Ho, Anthony D. [10 ]
Ivanova, Valentina
Vranowsky, Andrej [6 ]
Hipp, Joachim [5 ]
Oertel, Stefan [5 ]
机构：
[1] Technion Israel Inst Technol, Haifa, Israel
[2] Onkol Praxis, Jena, Germany
[3] Univ Roma La Sapienza, Cattedra Ematol, Rome, Italy
[4] Univ Pavia, Policlin San Matteo, Fdn IRCCS, Div Hematol, I-27100 Pavia, Italy
[5] Roche, Basel, Switzerland
[6] Natl Oncol Inst, Brastislawa, Slovakia
[7] Blokhin Canc Res Cencer, Moscow, Russia
[8] Disciplina Hematol Hosp Clin FMUSP, Sao Paulo, Brazil
[9] Mt Hosp, Perth, WA, Australia
[10] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1446 / 1446
页数：1
相关论文
共 50 条
  • [1] Early results from phase IIIb MAXIMA trial: Safety and efficacy in patients receiving maintenance Rituximab for follicular lymphoma
    Witzens-harig, M.
    Hipp, J.
    Ruffert, K.
    Becker, M.
    Hensel, M.
    Schwaner, I
    Fuxius, S.
    Gronschek, M.
    Pies, A.
    Schaefers, M.
    Schroeder, J.
    Ho, A.
    ONKOLOGIE, 2010, 33 : 159 - 159
  • [2] Safety in Patients Receiving Maintenance Rituximab for Follicular Lymphoma: Results from Phase IIIb MAXIMA Trial
    Witzens-Harig, Mathias
    Hipp, Joachim
    Ho, Anthony D.
    Nikolov, Nikolai
    Thurley, Daniel
    Hensel, Manfred
    Oertel, Stefan
    Wenger, Michael
    BLOOD, 2008, 112 (11) : 697 - 697
  • [3] Safety in patients receiving maintenance rituximab for follicular lymphoma: Results from the phase IIIb MAXIMA trial
    Wenger, M. K.
    Foa, R.
    Arcaini, L.
    Vranovsky, A.
    Ivanova, V.
    Van Hazel, G. A.
    Kurtovic, S.
    Duran, S.
    Gamba, E.
    Thurley, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Safety in patients receiving maintenance rituximab (Mabthera®) in follicular lymphoma:: Results from the phase IIIB maxima trial
    Thurley, D.
    Arcaini, L.
    Foa, R.
    Vranovsky, A.
    Ivanova, V.
    Van Hazel, G.
    Kurtovic, S.
    Duran, S.
    Gamba, E.
    Wenger, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 210 - 210
  • [5] Maintenance with rituximab is not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIB MAXIMA study
    Witzens-Harig, M.
    Di Rocco, A.
    van Hazel, G.
    Chamone, D.
    Ruffert, K.
    Rowe, J.
    Arcaini, L.
    Poddubnaya, I.
    Ho, A.
    Ivanova, V.
    Vranowsky, A.
    Oertel, S.
    Thurley, D.
    Foa, R.
    ONKOLOGIE, 2012, 35 : 46 - 46
  • [6] Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
    Witzens-Harig, Mathias
    Foa, Robin
    Di Rocco, Alice
    van Hazel, Guy
    Chamone, Dalton F. A.
    Rowe, Jacob M.
    Arcaini, Luca
    Poddubnaya, Irina
    Ho, Anthony D.
    Ivanova, Valentina
    Vranovsky, Andrej
    Thurley, Dan
    Oertel, Stephan
    ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1717 - 1724
  • [7] Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
    Mathias Witzens-Harig
    Robin Foá
    Alice Di Rocco
    Guy van Hazel
    Dalton F. A. Chamone
    Jacob M. Rowe
    Luca Arcaini
    Irina Poddubnaya
    Anthony D. Ho
    Valentina Ivanova
    Andrej Vranovsky
    Dan Thurley
    Stephan Oertel
    Annals of Hematology, 2014, 93 : 1717 - 1724
  • [8] Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
    Mathias Witzens-Harig
    Robin Foá
    Alice Di Rocco
    Guy van Hazel
    Dalton F. A. Chamone
    Jacob M. Rowe
    Luca Arcaini
    Irina Poddubnaya
    Anthony D. Ho
    Valentina Ivanova
    Andrej Vranovsky
    Dan Thurley
    Stephan Oertel
    Annals of Hematology, 2014, 93 : 1807 - 1807
  • [9] Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
    Niederwieser, Dietger
    Hamm, Caroline
    Cobb, Patrick
    Mo, Mindy
    Forsyth, Cecily
    Tucci, Alessandra
    Hanes, Vladimir
    Delwail, Vincent
    Hajek, Roman
    Chien, David
    TARGETED ONCOLOGY, 2020, 15 (05) : 599 - 611
  • [10] Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
    Dietger Niederwieser
    Caroline Hamm
    Patrick Cobb
    Mindy Mo
    Cecily Forsyth
    Alessandra Tucci
    Vladimir Hanes
    Vincent Delwail
    Roman Hajek
    David Chien
    Targeted Oncology, 2020, 15 : 599 - 611
12345